Update in the neurobiology of addiction


  • Ola ElSayed Nafea Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Zagazig University, Zagazig, Egypt




Addiction, Mechanism, Synaptic plasticity, BDNF, MicroRNA


Addiction is a major global health concern. Up to date, underlying the possible mechanisms of addiction have begun to yield fundamentally important insights to discover the novel therapeutics as there are very few effective treatments for addiction.  This review article is designed to outline the underlying mechanisms of addiction.


Metrics Loading ...


Koskela M, Back S, Voikar V, Richie CT, Domanskyi A, Harvey BK, et al. Update of neurotrophic factors in neurobiology of addiction and future directions. Neurobiol Dis. 2016;16:104-8.

Cadet JL, Bisagno V, Milroy CM. Neuropathology of substance use disorders. Acta Neuropathol. 2014;127:91-107.

Kauer JA, Malenka RC. Synaptic plasticity and addiction. Nat Rev Neurosci. 2007;8:844-58.

Luscher C, Malenka RC. Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron. 2011;69:650-63.

Oliva I, Wanat MJ. Ventral Tegmental Area Afferents and Drug-Dependent Behaviors. Front Psychiatry. 2016;7:30.

Vanderschuren LJ, Kalivas PW. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl). 2000;151:99-120.

Rahman S, McBride WJ. Feedback control of mesolimbic somatodendritic dopamine release in rat brain. J Neurochem. 2000;74:684-92.

Floresco SB. Prefrontal dopamine and behavioral flexibility: shifting from an "inverted-U" toward a family of functions. Front Neurosci. 2013;7:62.

Kalivas PW, McFarland K. Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl). 2003;168:44-56.

Heyer MP, Kenny PJ. Corticostriatal microRNAs in addiction. Brain Res. 2015;1628:2-16.

Cao X, Yeo G, Muotri AR, Kuwabara T, Gage FH. Noncoding RNAs in the mammalian central nervous system. Annu Rev Neurosci. 2006;29:77-103.

Kosik KS, Krichevsky AM. The Elegance of the MicroRNAs: A Neuronal Perspective. Neuron. 2005;47:779-82.

Xu X, Ji H, Liu G, Wang Q, Liu H, Shen W, et al. A significant association between BDNF promoter methylation and the risk of drug addiction. Gene. 2016;584:54-9.

Graham DL, Edwards S, Bachtell RK, DiLeone RJ, Rios M, Self DW. Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nat Neurosci. 2007;10:1029-37.

Grimm JW, Lu L, Hayashi T, Hope BT, Su TP, Shaham Y. Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J Neurosci. 2003;23:742-7.

Le Foll B, Diaz J, Sokoloff P. A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning. Neuroreport. 2005;16:175-8.

McFadden LM, Vieira-Brock PL, Hanson GR, Fleckenstein AE. Methamphetamine self-administration attenuates hippocampal serotonergic deficits: role of brain-derived neurotrophic factor. Int J Neuropsychopharmacol. 2014;17:1315-20.

Kim DJ, Roh S, Kim Y, Yoon SJ, Lee HK, Han CS, et al. High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users. Neurosci Lett. 2005;388:112-5.

Greenwald MK, Steinmiller CL, Sliwerska E, Lundahl L, Burmeister M. BDNF Val (66)Met genotype is associated with drug-seeking phenotypes in heroin-dependent individuals: a pilot study. Addict Biol. 2013;18:836-45.

Hou H, Qing Z, Jia S, Zhang X, Hu S, Hu J. Influence of brain-derived neurotrophic factor (val66met) genetic polymorphism on the ages of onset for heroin abuse in males. Brain Res. 2010;1353:245-8.

Sim MS, Mohamed Z, Hatim A, Rajagopal VL, Habil MH. Association of brain-derived neurotrophic factor (Val66Met) genetic polymorphism with methamphetamine dependence in a Malaysian population. Brain Res. 2010;1357:91-6.

Abbott LF, Nelson SB. Synaptic plasticity: taming the beast. Nat Neurosci. 2000;3:1178-83.

De Velasco EMF, McCall N, Wickman K. Chapter Six - GIRK Channel Plasticity and Implications for Drug Addiction. In: Paul AS, Kevin Ws, eds. International Review of Neurobiology: Academic Press; 2015: 201-238.

Winder D, Lovinger DM. Introduction to the special issue on synaptic plasticity and addiction. Neuropharmacology. 2011;61:1051.

Grueter BA, Rothwell PE, Malenka RC. Integrating synaptic plasticity and striatal circuit function in addiction. Curr Opin Neurobiol. 2012;22:545-51.

Bowers MS, Chen BT, Bonci A. AMPA receptor synaptic plasticity induced by psychostimulants: the past, present, and therapeutic future. Neuron. 2010;67:11-24.

Malenka RC, Bear MF. LTP and LTD: an embarrassment of riches. Neuron. 2004;44:5-21.

Volkow ND, Baler RD. Addiction science: Uncovering neurobiological complexity. Neuropharmacology. 2014;76:235-49.

Goodman J, Packard MG. Memory systems and the addicted brain. Front Psychiatry. 2016;7:24.






Review Articles